Ramelteon protects against human pulmonary microvascular endothelial cell injury induced by lipopolysaccharide (LPS) via activating nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway

Acute lung injury (ALI) is classified as a moderate or mild acute respiratory distress syndrome and is a prominent cause of morbidity and mortality among the critically ill population. Ramelteon is a melatonin receptor agonist with anti-inflammatory and antioxidant effects. The current study investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenjun, Zhang, Yang, Lu, Dahao, Huang, Tianfeng, Yan, Keshi, Wang, Weiwei, Gao, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805948/
https://www.ncbi.nlm.nih.gov/pubmed/34986734
http://dx.doi.org/10.1080/21655979.2021.2021065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805948/
https://www.ncbi.nlm.nih.gov/pubmed/34986734
http://dx.doi.org/10.1080/21655979.2021.2021065

Ejemplares similares